{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 686014, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:20:47Z", "timestamp": 1574493647492}, "reference-count": 41, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1704, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2011]]}, "DOI": "10.1002/pros.21351", "type": "journal-article", "created": {"date-parts": [[2011, 2, 9]], "date-time": "2011-02-09T13:56:55Z", "timestamp": 1297259815000}, "page": "n/a-n/a", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: Optimization from lead compound to CH5137291"], "prefix": "10.1002", "author": [{"given": "Hiromitsu", "family": "Kawata", "sequence": "first", "affiliation": []}, {"given": "Shinichi", "family": "Arai", "sequence": "additional", "affiliation": []}, {"given": "Toshito", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "Nobuyuki", "family": "Ishikura", "sequence": "additional", "affiliation": []}, {"given": "Ayako", "family": "Nishimoto", "sequence": "additional", "affiliation": []}, {"given": "Hitoshi", "family": "Yoshino", "sequence": "additional", "affiliation": []}, {"given": "Takuya", "family": "Shiraishi", "sequence": "additional", "affiliation": []}, {"given": "Kazutaka", "family": "Tachibana", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Haruhiko", "family": "Sato", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 2, 9]]}, "reference": [{"issue": "4", "key": "10.1002/pros.21351-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1093/annonc/mdm597", "article-title": "Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis", "volume": "19", "author": "Bosetti", "year": "2008", "journal-title": "Ann Oncol"}, {"issue": "4", "key": "10.1002/pros.21351-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.3322/caac.20006", "article-title": "Cancer statistics, 2009", "volume": "59", "author": "Jemal", "year": "2009", "journal-title": "CA Cancer J Clin"}, {"issue": "9", "key": "10.1002/pros.21351-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1093/jjco/hyn074", "article-title": "Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries", "volume": "38", "author": "Matsuda", "year": "2008", "journal-title": "Jpn J Clin Oncol"}, {"issue": "2", "key": "10.1002/pros.21351-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1002/ijc.23911", "article-title": "A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)", "volume": "124", "author": "Qiu", "year": "2009", "journal-title": "Int J Cancer"}, {"issue": "5", "key": "10.1002/pros.21351-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1053/hp.2000.6698", "article-title": "Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients", "volume": "31", "author": "Bubendorf", "year": "2000", "journal-title": "Hum Pathol"}, {"issue": "7", "key": "10.1002/pros.21351-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/S0046-8177(03)00190-4", "article-title": "Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone", "volume": "34", "author": "Roudier", "year": "2003", "journal-title": "Hum Pathol"}, {"issue": "24", "key": "10.1002/pros.21351-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "9209", "DOI": "10.1158/0008-5472.CAN-04-2442", "article-title": "Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program", "volume": "64", "author": "Shah", "year": "2004", "journal-title": "Cancer Res"}, {"issue": "15", "key": "10.1002/pros.21351-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "3437", "DOI": "10.1002/cncr.24395", "article-title": "Combined androgen blockade with bicalutamide for advanced prostate cancer: Long-term follow-up of a phase 3, double-blind, randomized study for survival", "volume": "115", "author": "Akaza", "year": "2009", "journal-title": "Cancer"}, {"issue": "12", "key": "10.1002/pros.21351-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1007/s00432-008-0409-z", "article-title": "Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: A multicenter, randomized, double-blind, comparative study", "volume": "134", "author": "Arai", "year": "2008", "journal-title": "J Cancer Res Clin Oncol"}, {"issue": "6", "key": "10.1002/pros.21351-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1184", "DOI": "10.1111/j.1464-410X.2006.06149.x", "article-title": "Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy", "volume": "97", "author": "Fujii", "year": "2006", "journal-title": "BJU Int"}, {"issue": "1", "key": "10.1002/pros.21351-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1016/S0022-5347(01)64039-4", "article-title": "High dose bicalutamide for androgen independent prostate cancer: Effect of prior hormonal therapy", "volume": "159", "author": "Joyce", "year": "1998", "journal-title": "J Urol"}, {"issue": "1", "key": "10.1002/pros.21351-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/S0090-4295(01)01010-X", "article-title": "Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group study (SWOG 9235)", "volume": "58", "author": "Kucuk", "year": "2001", "journal-title": "Urology"}, {"issue": "6", "key": "10.1002/pros.21351-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1111/j.1464-410X.2005.05766.x", "article-title": "Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer", "volume": "96", "author": "Miyake", "year": "2005", "journal-title": "BJU Int"}, {"issue": "3", "key": "10.1002/pros.21351-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1111/j.1442-2042.2007.01681.x", "article-title": "Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer", "volume": "14", "author": "Nishimura", "year": "2007", "journal-title": "Int J Urol"}, {"issue": "11", "key": "10.1002/pros.21351-BIB15|cit15", "first-page": "4315", "article-title": "A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy", "volume": "61", "author": "Gregory", "year": "2001", "journal-title": "Cancer Res"}, {"issue": "10", "key": "10.1002/pros.21351-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "3251", "DOI": "10.1158/1078-0432.CCR-08-1171", "article-title": "Castration-resistant prostate cancer: Locking up the molecular escape routes", "volume": "15", "author": "Attar", "year": "2009", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "10.1002/pros.21351-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1665", "DOI": "10.1158/1078-0432.CCR-06-0067", "article-title": "Mechanisms underlying the development of androgen-independent prostate cancer", "volume": "12", "author": "Pienta", "year": "2006", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "10.1002/pros.21351-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "1129", "DOI": "10.1016/j.eururo.2008.01.049", "article-title": "Progress in understanding androgen-independent prostate cancer (AIPC): A review of potential endocrine-mediated mechanisms", "volume": "53", "author": "Schroder", "year": "2008", "journal-title": "Eur Urol"}, {"issue": "21", "key": "10.1002/pros.21351-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "10613", "DOI": "10.1158/0008-5472.CAN-06-0028", "article-title": "Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression", "volume": "66", "author": "Cheng", "year": "2006", "journal-title": "Cancer Res"}, {"issue": "3-4", "key": "10.1002/pros.21351-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1016/j.jsbmb.2005.04.029", "article-title": "Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells", "volume": "96", "author": "Haag", "year": "2005", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "4", "key": "10.1002/pros.21351-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1158/1535-7163.MCT-04-0313", "article-title": "Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer", "volume": "4", "author": "Liao", "year": "2005", "journal-title": "Mol Cancer Ther"}, {"issue": "1", "key": "10.1002/pros.21351-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat Med"}, {"issue": "2", "key": "10.1002/pros.21351-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1038/sj.bjc.6690684", "article-title": "Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system", "volume": "81", "author": "Culig", "year": "1999", "journal-title": "Br J Cancer"}, {"issue": "7", "key": "10.1002/pros.21351-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1002/pros.21107", "article-title": "Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity", "volume": "70", "author": "Kawata", "year": "2010", "journal-title": "Prostate"}, {"issue": "9", "key": "10.1002/pros.21351-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "3159", "DOI": "10.1016/j.bmc.2010.03.036", "article-title": "Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists", "volume": "18", "author": "Yoshino", "year": "2010", "journal-title": "Bioorg Med Chem"}, {"issue": "2", "key": "10.1002/pros.21351-BIB26|cit26", "first-page": "163", "article-title": "VCaP, a cell-based model system of human prostate cancer", "volume": "15", "author": "Korenchuk", "year": "2001", "journal-title": "In Vivo"}, {"issue": "2", "key": "10.1002/pros.21351-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/j.urolonc.2005.11.005", "article-title": "Development of the VCaP androgen-independent model of prostate cancer", "volume": "24", "author": "Loberg", "year": "2006", "journal-title": "Urol Oncol"}, {"issue": "3", "key": "10.1002/pros.21351-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1038/sj.bjc.6601127", "article-title": "Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer", "volume": "89", "author": "Edwards", "year": "2003", "journal-title": "Br J Cancer"}, {"issue": "4", "key": "10.1002/pros.21351-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1038/ng0495-401", "article-title": "In vivo amplification of the androgen receptor gene and progression of human prostate cancer", "volume": "9", "author": "Visakorpi", "year": "1995", "journal-title": "Nat Genet"}, {"issue": "Pt 3", "key": "10.1002/pros.21351-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1042/bj2930761", "article-title": "Nuclear import of the human androgen receptor", "volume": "293", "author": "Jenster", "year": "1993", "journal-title": "Biochem J"}, {"issue": "29", "key": "10.1002/pros.21351-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "26321", "DOI": "10.1074/jbc.M203310200", "article-title": "Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor", "volume": "277", "author": "Masiello", "year": "2002", "journal-title": "J Biol Chem"}, {"issue": "3", "key": "10.1002/pros.21351-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1677/jme.0.0240339", "article-title": "Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, Casodex", "volume": "24", "author": "Waller", "year": "2000", "journal-title": "J Mol Endocrinol"}, {"issue": "13", "key": "10.1002/pros.21351-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "3001", "DOI": "10.1200/JCO.2002.10.018", "article-title": "Molecular biology of the androgen receptor", "volume": "20", "author": "Gelmann", "year": "2002", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "10.1002/pros.21351-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1210/er.2002-0032", "article-title": "Androgen receptor in prostate cancer", "volume": "25", "author": "Heinlein", "year": "2004", "journal-title": "Endocr Rev"}, {"issue": "1", "key": "10.1002/pros.21351-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1016/j.canlet.2004.12.037", "article-title": "Molecular chaperones throughout the life cycle of the androgen receptor", "volume": "231", "author": "Prescott", "year": "2006", "journal-title": "Cancer Lett"}, {"issue": "Pt 7", "key": "10.1002/pros.21351-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1242/jcs.022103", "article-title": "Structural basis for the nuclear import of the human androgen receptor", "volume": "121", "author": "Cutress", "year": "2008", "journal-title": "J Cell Sci"}, {"issue": "9", "key": "10.1002/pros.21351-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "4514", "DOI": "10.1158/0008-5472.CAN-06-1701", "article-title": "The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor", "volume": "67", "author": "Haelens", "year": "2007", "journal-title": "Cancer Res"}, {"issue": "11", "key": "10.1002/pros.21351-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "6162", "DOI": "10.1210/jc.2005-0179", "article-title": "Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients", "volume": "90", "author": "Kawate", "year": "2005", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "1-2", "key": "10.1002/pros.21351-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/0960-0760(94)90114-7", "article-title": "Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite", "volume": "51", "author": "Cousty-Berlin", "year": "1994", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "5928", "key": "10.1002/pros.21351-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1126/science.1168175", "article-title": "Development of a second-generation antiandrogen for treatment of advanced prostate cancer", "volume": "324", "author": "Tran", "year": "2009", "journal-title": "Science"}, {"issue": "9724", "key": "10.1002/pros.21351-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "1437", "DOI": "10.1016/S0140-6736(10)60172-9", "article-title": "Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study", "volume": "375", "author": "Scher", "year": "2010", "journal-title": "Lancet"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21351", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T19:34:15Z", "timestamp": 1497900855000}, "score": 85.64636, "issued": {"date-parts": [[2011]]}, "references-count": 41, "URL": "http://dx.doi.org/10.1002/pros.21351", "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:47:03Z", "timestamp": 1574484423750}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 12, 10]]}, "DOI": "10.1158/1535-7163.targ-09-a220", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T06:38:29Z", "timestamp": 1340779109000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract A220: Design and synthesis of an androgen receptor pure antagonist (CH5137291) for treatment of castration\u2010resistant prostate cancer"], "prefix": "10.1158", "author": [{"given": "Takuya", "family": "Shiraishi", "sequence": "first", "affiliation": []}, {"given": "Haruhiko", "family": "Sato", "sequence": "additional", "affiliation": []}, {"given": "Kazutaka", "family": "Tachibana", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Emura", "sequence": "additional", "affiliation": []}, {"given": "Hitoshi", "family": "Yoshino", "sequence": "additional", "affiliation": []}, {"given": "Akie", "family": "Honma", "sequence": "additional", "affiliation": []}, {"given": "Nobuyuki", "family": "Ishikura", "sequence": "additional", "affiliation": []}, {"given": "Toshiaki", "family": "Tsunenari", "sequence": "additional", "affiliation": []}, {"given": "Miho", "family": "Watanabe", "sequence": "additional", "affiliation": []}, {"given": "Ayako", "family": "Nishimoto", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Toshito", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "Masateru", "family": "Ohta", "sequence": "additional", "affiliation": []}, {"given": "Noriyuki", "family": "Takata", "sequence": "additional", "affiliation": []}, {"given": "Kentaro", "family": "Furumoto", "sequence": "additional", "affiliation": []}, {"given": "Kazuya", "family": "Kimura", "sequence": "additional", "affiliation": []}, {"given": "Hiromitsu", "family": "Kawata", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 10, 24]]}, "event": {"name": "Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA"}, "container-title": ["Hormonal Agents and Therapy"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-09-A220", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:42:13Z", "timestamp": 1557430933000}, "score": 57.189167, "issued": {"date-parts": [[2009, 12, 10]]}, "references-count": 0, "alternative-id": ["10.1158/1535-7163.TARG-09-A220"], "URL": "http://dx.doi.org/10.1158/1535-7163.targ-09-a220"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:47:03Z", "timestamp": 1574484423743}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 12, 10]]}, "DOI": "10.1158/1535-7163.targ-09-a219", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T06:38:29Z", "timestamp": 1340779109000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract A219: Universal efficacy of novel androgen receptor pure antagonist, CH5137291, against broad spectrum prostate cancer including castration\u2010resistant prostate cancers"], "prefix": "10.1158", "author": [{"given": "Nobuyuki", "family": "Ishikura", "sequence": "first", "affiliation": []}, {"given": "Hiromitsu", "family": "Kawata", "sequence": "additional", "affiliation": []}, {"given": "Ayako", "family": "Nishimoto", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Toshiaki", "family": "Tsunenari", "sequence": "additional", "affiliation": []}, {"given": "Miho", "family": "Watanabe", "sequence": "additional", "affiliation": []}, {"given": "Takuya", "family": "Shiraishi", "sequence": "additional", "affiliation": []}, {"given": "Kazutaka", "family": "Tachibana", "sequence": "additional", "affiliation": []}, {"given": "Hitoshi", "family": "Yoshino", "sequence": "additional", "affiliation": []}, {"given": "Akie", "family": "Honma", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Emura", "sequence": "additional", "affiliation": []}, {"given": "Masateru", "family": "Ohta", "sequence": "additional", "affiliation": []}, {"given": "Toshito", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "Takao", "family": "Houjo", "sequence": "additional", "affiliation": []}, {"given": "Eva", "family": "Corey", "sequence": "additional", "affiliation": []}, {"given": "Robert L.", "family": "Vessella", "sequence": "additional", "affiliation": []}, {"given": "Yuko", "family": "Aoki", "sequence": "additional", "affiliation": []}, {"given": "Haruhiko", "family": "Sato", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 10, 24]]}, "event": {"name": "Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA"}, "container-title": ["Hormonal Agents and Therapy"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-09-A219", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:42:17Z", "timestamp": 1557430937000}, "score": 56.465065, "issued": {"date-parts": [[2009, 12, 10]]}, "references-count": 0, "alternative-id": ["10.1158/1535-7163.TARG-09-A219"], "URL": "http://dx.doi.org/10.1158/1535-7163.targ-09-a219"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T20:21:00Z", "timestamp": 1574540460694}, "publisher-location": "New York, NY", "reference-count": 70, "publisher": "Springer New York", "isbn-type": [{"value": "9781493911752", "type": "print"}, {"value": "9781493911769", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014]]}, "DOI": "10.1007/978-1-4939-1176-9_5", "type": "book-chapter", "created": {"date-parts": [[2014, 8, 20]], "date-time": "2014-08-20T10:21:32Z", "timestamp": 1408530092000}, "page": "67-75", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Androgen Receptor Biology in Castration Resistant Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Heather H.", "family": "Cheng", "sequence": "first", "affiliation": []}, {"given": "Bruce", "family": "Montgomery", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 7, 21]]}, "reference": [{"issue": "1", "key": "5_CR1", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.3322/caac.21166", "volume": "63", "author": "R Siegel", "year": "2013", "unstructured": "Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330. Epub 2013/01/22.", "journal-title": "CA Cancer J Clin"}, {"issue": "2", "key": "5_CR2", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1001/archsurg.1941.01210140043004", "volume": "42", "author": "C Huggins", "year": "1941", "unstructured": "Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg. 1941;42(2):209\u201323.", "journal-title": "Arch Surg"}, {"key": "5_CR3", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/S0083-6729(02)65062-9", "volume": "65", "author": "JL Walcott", "year": "2002", "unstructured": "Walcott JL, Merry DE. Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy. Vitam Horm. 2002;65:127\u201347. Epub 2002/12/17.", "journal-title": "Vitam Horm"}, {"issue": "32", "key": "5_CR4", "doi-asserted-by": "publisher", "first-page": "20213", "DOI": "10.1074/jbc.273.32.20213", "volume": "273", "author": "KE Knudsen", "year": "1998", "unstructured": "Knudsen KE, Arden KC, Cavenee WK. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. J Biol Chem. 1998;273(32):20213\u201322.", "journal-title": "J Biol Chem"}, {"issue": "2", "key": "5_CR5", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1016/j.cell.2009.04.056", "volume": "138", "author": "Q Wang", "year": "2009", "unstructured": "Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 2009;138(2):245\u201356. Epub 2009/07/28.", "journal-title": "Cell"}, {"issue": "15", "key": "5_CR6", "doi-asserted-by": "publisher", "first-page": "7783", "DOI": "10.1158/0008-5472.CAN-05-4472", "volume": "66", "author": "Y Xu", "year": "2006", "unstructured": "Xu Y, Chen SY, Ross KN, Balk SP. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res. 2006;66(15):7783\u201392.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "5_CR7", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/j.ccr.2011.09.001", "volume": "20", "author": "C Cai", "year": "2011", "unstructured": "Cai C, He HH, Chen S, Coleman I, Wang H, Fang Z, et al. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell. 2011;20(4):457\u201371. Epub 2011/10/22.", "journal-title": "Cancer Cell"}, {"issue": "21", "key": "5_CR8", "doi-asserted-by": "publisher", "first-page": "1869", "DOI": "10.1093/jnci/91.21.1869", "volume": "91", "author": "DB Agus", "year": "1999", "unstructured": "Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW, et al. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst. 1999;91(21):1869\u201376.", "journal-title": "J Natl Cancer Inst"}, {"issue": "1", "key": "5_CR9", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1002/pros.10271", "volume": "57", "author": "AB Smitherman", "year": "2003", "unstructured": "Smitherman AB, Gregory CW, Mohler JL. Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograft. Prostate. 2003;57(1):24\u201331. Epub 2003/07/30.", "journal-title": "Prostate"}, {"issue": "4", "key": "5_CR10", "doi-asserted-by": "publisher", "first-page": "670", "DOI": "10.1038/bjc.1998.107", "volume": "77", "author": "P Stattin", "year": "1998", "unstructured": "Stattin P, Westin P, Damber JE, Bergh A. Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer. Br J Cancer. 1998;77(4):670\u20135. Epub 1998/03/04.", "journal-title": "Br J Cancer"}, {"issue": "4", "key": "5_CR11", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1002/pros.20139", "volume": "62", "author": "N Ohlson", "year": "2005", "unstructured": "Ohlson N, Wikstrom P, Stattin P, Bergh A. Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment. Prostate. 2005;62(4):307\u201315. Epub 2004/09/25.", "journal-title": "Prostate"}, {"issue": "1", "key": "5_CR12", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1038/ng1935", "volume": "39", "author": "SA Tomlins", "year": "2007", "unstructured": "Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet. 2007;39(1):41\u201351. Epub 2006/12/19.", "journal-title": "Nat Genet"}, {"issue": "11", "key": "5_CR13", "doi-asserted-by": "publisher", "first-page": "4447", "DOI": "10.1158/0008-5472.CAN-08-0249", "volume": "68", "author": "RB Montgomery", "year": "2008", "unstructured": "Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res. 2008;68(11):4447\u201354. Epub 2008/06/04.", "journal-title": "Cancer Res"}, {"issue": "15", "key": "5_CR14", "doi-asserted-by": "publisher", "first-page": "6407", "DOI": "10.1158/0008-5472.CAN-07-5997", "volume": "68", "author": "JA Locke", "year": "2008", "unstructured": "Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, et al. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res. 2008;68(15):6407\u201315. Epub 2008/08/05.", "journal-title": "Cancer Res"}, {"issue": "33", "key": "5_CR15", "doi-asserted-by": "publisher", "first-page": "13728", "DOI": "10.1073/pnas.1107898108", "volume": "108", "author": "KH Chang", "year": "2011", "unstructured": "Chang KH, Li R, Papari-Zareei M, Watumull L, Zhao YD, Auchus RJ, et al. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2011;108(33):13728\u201333. Epub 2011/07/29.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "5_CR16", "doi-asserted-by": "publisher", "first-page": "R25", "DOI": "10.1530/JME-11-0018", "volume": "47", "author": "M Shiota", "year": "2011", "unstructured": "Shiota M, Yokomizo A, Naito S. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. J Mol Endocrinol. 2011;47(1):R25\u201341. Epub 2011/04/21.", "journal-title": "J Mol Endocrinol"}, {"issue": "1", "key": "5_CR17", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/nm972", "volume": "10", "author": "CD Chen", "year": "2004", "unstructured": "Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10(1):33\u20139.", "journal-title": "Nat Med"}, {"issue": "28", "key": "5_CR18", "doi-asserted-by": "publisher", "first-page": "4563", "DOI": "10.1200/JCO.2007.15.9749", "volume": "26", "author": "G Attard", "year": "2008", "unstructured": "Attard G, Reid AH, Yap TA, Raynaud F, Dowsett M, Settatree S, et al. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J Clin Oncol. 2008;26(28):4563\u201371. Epub 2008/07/23.", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "5_CR19", "doi-asserted-by": "publisher", "first-page": "1481", "DOI": "10.1200/JCO.2009.24.1281", "volume": "28", "author": "CJ Ryan", "year": "2010", "unstructured": "Ryan CJ, Smith MR, Fong L, Rosenberg JE, Kantoff P, Raynaud F, et al. Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy. J Clin Oncol. 2010;28(9):1481\u20138. Epub 2010/02/18.", "journal-title": "J Clin Oncol"}, {"issue": "18", "key": "5_CR20", "doi-asserted-by": "publisher", "first-page": "5913", "DOI": "10.1158/1078-0432.CCR-11-0728", "volume": "17", "author": "EA Mostaghel", "year": "2011", "unstructured": "Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, et al. Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res. 2011;17(18):5913\u201325. Epub 2011/08/03.", "journal-title": "Clin Cancer Res"}, {"issue": "21", "key": "5_CR21", "doi-asserted-by": "publisher", "first-page": "1995", "DOI": "10.1056/NEJMoa1014618", "volume": "364", "author": "JS Bono de", "year": "2011", "unstructured": "de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364(21):1995\u20132005. Epub 2011/05/27.", "journal-title": "N Engl J Med"}, {"issue": "12", "key": "5_CR22", "doi-asserted-by": "publisher", "first-page": "1210", "DOI": "10.1016/S1470-2045(12)70473-4", "volume": "13", "author": "CJ Logothetis", "year": "2012", "unstructured": "Logothetis CJ, Basch E, Molina A, Fizazi K, North SA, Chi KN, et al. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. Lancet Oncol. 2012;13(12):1210\u20137. Epub 2012/11/13.", "journal-title": "Lancet Oncol"}, {"issue": "13", "key": "5_CR23", "doi-asserted-by": "publisher", "first-page": "1187", "DOI": "10.1056/NEJMoa1207506", "volume": "367", "author": "HI Scher", "year": "2012", "unstructured": "Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367(13):1187\u201397. Epub 2012/08/17.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "5_CR24", "doi-asserted-by": "publisher", "first-page": "1335", "DOI": "10.1158/1078-0432.CCR-12-2910", "volume": "19", "author": "J Hoffman-Censits", "year": "2013", "unstructured": "Hoffman-Censits J, Kelly WK. Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer. Clin Cancer Res. 2013;19(6):1335\u20139. Epub 2013/01/10.", "journal-title": "Clin Cancer Res"}, {"issue": "21", "key": "5_CR25", "doi-asserted-by": "publisher", "first-page": "1393", "DOI": "10.1056/NEJM199505253322101", "volume": "332", "author": "ME Taplin", "year": "1995", "unstructured": "Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med. 1995;332(21):1393\u20138. Epub 1995/05/25.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "5_CR26", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1038/ncponc0765", "volume": "4", "author": "ME Taplin", "year": "2007", "unstructured": "Taplin ME. Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol. 2007;4(4):236\u201344. Epub 2007/03/30.", "journal-title": "Nat Clin Pract Oncol"}, {"issue": "1", "key": "5_CR27", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.2174/138920209787581307", "volume": "10", "author": "GN Brooke", "year": "2009", "unstructured": "Brooke GN, Bevan CL. The role of androgen receptor mutations in prostate cancer progression. Curr Genomics. 2009;10(1):18\u201325.", "journal-title": "Curr Genomics"}, {"issue": "14", "key": "5_CR28", "doi-asserted-by": "publisher", "first-page": "2673", "DOI": "10.1200/JCO.2003.11.102", "volume": "21", "author": "ME Taplin", "year": "2003", "unstructured": "Taplin ME, Rajeshkumar B, Halabi S, Werner CP, Woda BA, Picus J, et al. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol. 2003;21(14):2673\u20138. Epub 2003/07/16.", "journal-title": "J Clin Oncol"}, {"key": "5_CR29", "doi-asserted-by": "publisher", "first-page": "1030", "DOI": "10.1158/2159-8290.CD-13-0142", "volume": "3", "author": "M Korpal", "year": "2013", "unstructured": "Korpal M, Korn JM, Gao X, Rakiec DP, Ruddy DA, Doshi S, et al. An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov. 2013;3:1030\u201343. Epub 2013/07/12.", "journal-title": "Cancer Discov"}, {"key": "5_CR30", "doi-asserted-by": "publisher", "first-page": "1020", "DOI": "10.1158/2159-8290.CD-13-0226", "volume": "3", "author": "JD Joseph", "year": "2013", "unstructured": "Joseph JD, Lu N, Qian J, Sensintaffar J, Shao G, Brigham D, et al. A clinically relevant androgen receptor mutation confers resistance to 2nd generation anti-androgens enzalutamide and ARN-509. Cancer Discov. 2013;3:1020\u20139. Epub 2013/06/20.", "journal-title": "Cancer Discov"}, {"key": "5_CR31", "doi-asserted-by": "publisher", "first-page": "e00499", "DOI": "10.7554/eLife.00499", "volume": "2", "author": "MD Balbas", "year": "2013", "unstructured": "Balbas MD, Evans MJ, Hosfield DJ, Wongvipat J, Arora VK, Watson PA, et al. Overcoming mutation-based resistance to antiandrogens with rational drug design. eLife. 2013;2:e00499. Epub 2013/04/13.", "journal-title": "eLife"}, {"issue": "4", "key": "5_CR32", "doi-asserted-by": "publisher", "first-page": "e19059", "DOI": "10.1371/journal.pone.0019059", "volume": "6", "author": "E Hornberg", "year": "2011", "unstructured": "Hornberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, et al. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One. 2011;6(4):e19059. Epub 2011/05/10.", "journal-title": "PLoS One"}, {"issue": "13", "key": "5_CR33", "doi-asserted-by": "publisher", "first-page": "5469", "DOI": "10.1158/0008-5472.CAN-08-0594", "volume": "68", "author": "SM Dehm", "year": "2008", "unstructured": "Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res. 2008;68(13):5469\u201377. Epub 2008/07/03.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "5_CR34", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1158/0008-5472.CAN-08-2764", "volume": "69", "author": "R Hu", "year": "2009", "unstructured": "Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, et al. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res. 2009;69(1):16\u201322. Epub 2009/01/02.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "5_CR35", "doi-asserted-by": "publisher", "first-page": "2305", "DOI": "10.1158/0008-5472.CAN-08-3795", "volume": "69", "author": "Z Guo", "year": "2009", "unstructured": "Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, et al. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res. 2009;69(6):2305\u201313. Epub 2009/02/27.", "journal-title": "Cancer Res"}, {"issue": "8", "key": "5_CR36", "doi-asserted-by": "publisher", "first-page": "2715", "DOI": "10.1172/JCI41824", "volume": "120", "author": "S Sun", "year": "2010", "unstructured": "Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, et al. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Invest. 2010;120(8):2715\u201330. Epub 2010/07/21.", "journal-title": "J Clin Invest"}, {"key": "5_CR37", "doi-asserted-by": "publisher", "first-page": "1656", "DOI": "10.1002/pros.21382", "volume": "71", "author": "R Hu", "year": "2011", "unstructured": "Hu R, Isaacs WB, Luo J. A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities. Prostate. 2011;71:1656\u201367. Epub 2011/03/30.", "journal-title": "Prostate"}, {"issue": "24", "key": "5_CR38", "doi-asserted-by": "publisher", "first-page": "3971", "DOI": "10.1007/s00018-011-0766-7", "volume": "68", "author": "S Haile", "year": "2011", "unstructured": "Haile S, Sadar MD. Androgen receptor and its splice variants in prostate cancer. Cell Mol Life Sci. 2011;68(24):3971\u201381. Epub 2011/07/13.", "journal-title": "Cell Mol Life Sci"}, {"issue": "14", "key": "5_CR39", "doi-asserted-by": "publisher", "first-page": "3457", "DOI": "10.1158/0008-5472.CAN-11-3892", "volume": "72", "author": "R Hu", "year": "2012", "unstructured": "Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, et al. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res. 2012;72(14):3457\u201362. Epub 2012/06/20.", "journal-title": "Cancer Res"}, {"key": "5_CR40", "unstructured": "Liu LL, Xie N, Sun S, Plymate S, Mostaghel E, Dong X. Mechanisms of the androgen receptor splicing in prostate cancer cells. Oncogene. 2013. Epub 2013/07/16"}, {"issue": "45", "key": "5_CR41", "doi-asserted-by": "publisher", "first-page": "4759", "DOI": "10.1038/onc.2011.637", "volume": "31", "author": "Y Li", "year": "2012", "unstructured": "Li Y, Hwang TH, Oseth LA, Hauge A, Vessella RL, Schmechel SC, et al. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression. Oncogene. 2012;31(45):4759\u201367. Epub 2012/01/24.", "journal-title": "Oncogene"}, {"issue": "18", "key": "5_CR42", "doi-asserted-by": "publisher", "first-page": "6019", "DOI": "10.1158/0008-5472.CAN-11-1417", "volume": "71", "author": "MS Darshan", "year": "2011", "unstructured": "Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D, Zhou XK, et al. Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res. 2011;71(18):6019\u201329. Epub 2011/07/30.", "journal-title": "Cancer Res"}, {"issue": "20", "key": "5_CR43", "doi-asserted-by": "publisher", "first-page": "7992", "DOI": "10.1158/0008-5472.CAN-10-0585", "volume": "70", "author": "ML Zhu", "year": "2010", "unstructured": "Zhu ML, Horbinski CM, Garzotto M, Qian DZ, Beer TM, Kyprianou N. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res. 2010;70(20):7992\u20138002. Epub 2010/09/03.", "journal-title": "Cancer Res"}, {"issue": "18", "key": "5_CR44", "doi-asserted-by": "publisher", "first-page": "4611", "DOI": "10.1158/0008-5472.CAN-12-0783", "volume": "72", "author": "M Thadani-Mulero", "year": "2012", "unstructured": "Thadani-Mulero M, Nanus DM, Giannakakou P. Androgen receptor on the move: boarding the microtubule expressway to the nucleus. Cancer Res. 2012;72(18):4611\u20135. Epub 2012/09/19.", "journal-title": "Cancer Res"}, {"issue": "23", "key": "5_CR45", "doi-asserted-by": "publisher", "first-page": "19736", "DOI": "10.1074/jbc.M112.352930", "volume": "287", "author": "SC Chan", "year": "2012", "unstructured": "Chan SC, Li Y, Dehm SM. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal. J Biol Chem. 2012;287(23):19736\u201349. Epub 2012/04/26.", "journal-title": "J Biol Chem"}, {"key": "5_CR46", "doi-asserted-by": "publisher", "first-page": "2270", "DOI": "10.1158/0008-5472.CAN-13-2876", "volume": "74", "author": "M Thadani-Mulero", "year": "2014", "unstructured": "Thadani-Mulero M, Matov A, Nanus DM, Plymate SR, Giannakakou P. Taxane sensitivity in prostate cancer is determined by androgen receptor splice variants. Cancer Res. 2014;74:2270\u201382.", "journal-title": "Cancer Res"}, {"key": "5_CR47", "doi-asserted-by": "publisher", "first-page": "1198", "DOI": "10.1016/j.eururo.2013.07.022", "volume": "65", "author": "JM Fitzpatrick", "year": "2014", "unstructured": "Fitzpatrick JM, de Wit R. Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2014;65:1198\u2013204. Epub 2013/08/06.", "journal-title": "Eur Urol"}, {"issue": "19", "key": "5_CR48", "doi-asserted-by": "publisher", "first-page": "3962", "DOI": "10.1038/emboj.2011.328", "volume": "30", "author": "B Sahu", "year": "2011", "unstructured": "Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. Embo J. 2011;30(19):3962\u201376. Epub 2011/09/15.", "journal-title": "Embo J"}, {"issue": "6", "key": "5_CR49", "doi-asserted-by": "publisher", "first-page": "1309", "DOI": "10.1016/j.cell.2013.11.012", "volume": "155", "author": "VK Arora", "year": "2013", "unstructured": "Arora VK, Schenkein E, Murali R, Subudhi SK, Wongvipat J, Balbas MD, et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell. 2013;155(6):1309\u201322. Epub 2013/12/10.", "journal-title": "Cell"}, {"key": "5_CR50", "unstructured": "Sawyers CL, editor. Overcoming resistance to cancer drug therapy. In: ASCO annual meeting; 2013."}, {"key": "5_CR51", "unstructured": "Scher HI, Fizazi K, Saad F, Chi K, Taplin ME, Sternberg CN, et al., editors. Association of baseline corticosteroid with outcomes in a multivariate analysis of the phase 3 affirm study of enzalutamide (ENZA), an androgen receptor signaling inhibitor (ARSI). ESMO; 2012."}, {"key": "5_CR52", "unstructured": "Montgomery B, Kheoh S, Molina A, Li J, Bellmunt J, Ryan CJ, et al. Effect of corticosteroid (CS) use at baseline (CUB) on overall survival (OS) in patients (pts) receiving abiraterone acetate (AA): Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D). In: 2013 ASCO annual meeting; 2013."}, {"issue": "11", "key": "5_CR53", "doi-asserted-by": "publisher", "first-page": "3028", "DOI": "10.1158/1078-0432.CCR-09-3122", "volume": "16", "author": "TB Dorff", "year": "2010", "unstructured": "Dorff TB, Goldman B, Pinski JK, Mack PC, Lara Jr PN, Van Veldhuizen Jr PJ, et al. Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res. 2010;16(11):3028\u201334. Epub 2010/05/21.", "journal-title": "Clin Cancer Res"}, {"issue": "20", "key": "5_CR54", "first-page": "4640", "volume": "58", "author": "A Hobisch", "year": "1998", "unstructured": "Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, et al. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 1998;58(20):4640\u20135. Epub 1998/10/27.", "journal-title": "Cancer Res"}, {"issue": "13", "key": "5_CR55", "doi-asserted-by": "publisher", "first-page": "5965", "DOI": "10.1158/0008-5472.CAN-04-2837", "volume": "65", "author": "JD Debes", "year": "2005", "unstructured": "Debes JD, Comuzzi B, Schmidt LJ, Dehm SM, Culig Z, Tindall DJ. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6. Cancer Res. 2005;65(13):5965\u201373. Epub 2005/07/05.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "5_CR56", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1016/j.ejca.2011.10.014", "volume": "48", "author": "K Fizazi", "year": "2012", "unstructured": "Fizazi K, De Bono JS, Flechon A, Heidenreich A, Voog E, Davis NB, et al. Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. Eur J Cancer. 2012;48(1):85\u201393. Epub 2011/12/02.", "journal-title": "Eur J Cancer"}, {"issue": "4", "key": "5_CR57", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/j.ccr.2006.08.021", "volume": "10", "author": "Z Guo", "year": "2006", "unstructured": "Guo Z, Dai B, Jiang T, Xu K, Xie Y, Kim O, et al. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell. 2006;10(4):309\u201319. Epub 2006/10/19.", "journal-title": "Cancer Cell"}, {"issue": "30", "key": "5_CR58", "doi-asserted-by": "publisher", "first-page": "20989", "DOI": "10.1074/jbc.M802392200", "volume": "283", "author": "LA Ponguta", "year": "2008", "unstructured": "Ponguta LA, Gregory CW, French FS, Wilson EM. Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer. J Biol Chem. 2008;283(30):20989\u20131001. Epub 2008/05/31.", "journal-title": "J Biol Chem"}, {"issue": "13", "key": "5_CR59", "doi-asserted-by": "publisher", "first-page": "5587", "DOI": "10.1158/0008-5472.CAN-09-4610", "volume": "70", "author": "B Dai", "year": "2010", "unstructured": "Dai B, Chen H, Guo S, Yang X, Linn DE, Sun F, et al. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells. Cancer Res. 2010;70(13):5587\u201396. Epub 2010/06/24.", "journal-title": "Cancer Res"}, {"issue": "5", "key": "5_CR60", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/j.ccr.2004.09.031", "volume": "6", "author": "IK Mellinghoff", "year": "2004", "unstructured": "Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell. 2004;6(5):517\u201327. Epub 2004/11/16.", "journal-title": "Cancer Cell"}, {"issue": "8", "key": "5_CR61", "doi-asserted-by": "publisher", "first-page": "3065", "DOI": "10.1158/1078-0432.CCR-04-1586", "volume": "11", "author": "JD Wu", "year": "2005", "unstructured": "Wu JD, Odman A, Higgins LM, Haugk K, Vessella R, Ludwig DL, et al. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. Clin Cancer Res. 2005;11(8):3065\u201374.", "journal-title": "Clin Cancer Res"}, {"issue": "22", "key": "5_CR62", "doi-asserted-by": "publisher", "first-page": "11047", "DOI": "10.1158/0008-5472.CAN-06-0596", "volume": "66", "author": "S Kraus", "year": "2006", "unstructured": "Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res. 2006;66(22):11047\u201354. Epub 2006/11/17.", "journal-title": "Cancer Res"}, {"issue": "13", "key": "5_CR63", "doi-asserted-by": "publisher", "first-page": "1307", "DOI": "10.1016/S1470-2045(13)70479-0", "volume": "14", "author": "JC Araujo", "year": "2013", "unstructured": "Araujo JC, Trudel GC, Saad F, Armstrong AJ, Yu EY, Bellmunt J, et al. Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. Lancet Oncol. 2013;14(13):1307\u201316. Epub 2013/11/12.", "journal-title": "Lancet Oncol"}, {"issue": "3", "key": "5_CR64", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1200/JCO.2006.07.0888", "volume": "25", "author": "JS Bono de", "year": "2007", "unstructured": "de Bono JS, Bellmunt J, Attard G, Droz JP, Miller K, Flechon A, et al. Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer. J Clin Oncol. 2007;25(3):257\u201362. Epub 2007/01/20.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "5_CR65", "doi-asserted-by": "publisher", "first-page": "609", "DOI": "10.1097/COC.0b013e3181beac33", "volume": "33", "author": "SS Sridhar", "year": "2010", "unstructured": "Sridhar SS, Hotte SJ, Chin JL, Hudes GR, Gregg R, Trachtenberg J, et al. A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer. Am J Clin Oncol. 2010;33(6):609\u201313. Epub 2010/01/01.", "journal-title": "Am J Clin Oncol"}, {"issue": "3", "key": "5_CR66", "doi-asserted-by": "publisher", "first-page": "380", "DOI": "10.1016/j.molcel.2007.05.041", "volume": "27", "author": "Q Wang", "year": "2007", "unstructured": "Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell. 2007;27(3):380\u201392. Epub 2007/08/07.", "journal-title": "Mol Cell"}, {"issue": "5", "key": "5_CR67", "doi-asserted-by": "publisher", "first-page": "1570", "DOI": "10.1158/0008-5472.CAN-12-2350", "volume": "73", "author": "B Sahu", "year": "2013", "unstructured": "Sahu B, Laakso M, Pihlajamaa P, Ovaska K, Sinielnikov I, Hautaniemi S, et al. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells. Cancer Res. 2013;73(5):1570\u201380. Epub 2012/12/28.", "journal-title": "Cancer Res"}, {"issue": "7", "key": "5_CR68", "doi-asserted-by": "publisher", "first-page": "3422", "DOI": "10.1158/0008-5472.CAN-06-2836", "volume": "67", "author": "HV Heemers", "year": "2007", "unstructured": "Heemers HV, Sebo TJ, Debes JD, Regan KM, Raclaw KA, Murphy LM, et al. Androgen deprivation increases p300 expression in prostate cancer cells. Cancer Res. 2007;67(7):3422\u201330. Epub 2007/04/06.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "5_CR69", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1200/JCO.2010.33.7675", "volume": "30", "author": "E Efstathiou", "year": "2012", "unstructured": "Efstathiou E, Titus M, Tsavachidou D, Tzelepi V, Wen S, Hoang A, et al. Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. J Clin Oncol. 2012;30(6):637\u201343. Epub 2011/12/21.", "journal-title": "J Clin Oncol"}, {"key": "5_CR70", "doi-asserted-by": "publisher", "first-page": "791", "DOI": "10.1158/1078-0432.CCR-12-3601", "volume": "20", "author": "EA Mostaghel", "year": "2014", "unstructured": "Mostaghel EA, Plymate SR, Montgomery B. Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit. Clin Cancer Res. 2014;20:791\u20138. Epub 2013/12/07.", "journal-title": "Clin Cancer Res"}], "container-title": ["Management of Castration Resistant Prostate Cancer", "Current Clinical Urology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-1176-9_5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 27]], "date-time": "2019-05-27T16:28:11Z", "timestamp": 1558974491000}, "score": 49.13408, "issued": {"date-parts": [[2014]]}, "ISBN": ["9781493911752", "9781493911769"], "references-count": 70, "URL": "http://dx.doi.org/10.1007/978-1-4939-1176-9_5", "relation": {"cites": []}, "ISSN": ["2197-7194", "2197-7208"], "issn-type": [{"value": "2197-7194", "type": "print"}, {"value": "2197-7208", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:58:12Z", "timestamp": 1574470692128}, "reference-count": 19, "publisher": "Elsevier BV", "issue": "23", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 12, 1]], "date-time": "2010-12-01T00:00:00Z", "timestamp": 1291161600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioorganic & Medicinal Chemistry"], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1016/j.bmc.2010.10.023", "type": "journal-article", "created": {"date-parts": [[2010, 10, 18]], "date-time": "2010-10-18T05:45:27Z", "timestamp": 1287380727000}, "page": "8150-8157", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Hitoshi", "family": "Yoshino", "sequence": "first", "affiliation": []}, {"given": "Haruhiko", "family": "Sato", "sequence": "additional", "affiliation": []}, {"given": "Takuya", "family": "Shiraishi", "sequence": "additional", "affiliation": []}, {"given": "Kazutaka", "family": "Tachibana", "sequence": "additional", "affiliation": []}, {"given": "Takashi", "family": "Emura", "sequence": "additional", "affiliation": []}, {"given": "Akie", "family": "Honma", "sequence": "additional", "affiliation": []}, {"given": "Nobuyuki", "family": "Ishikura", "sequence": "additional", "affiliation": []}, {"given": "Toshiaki", "family": "Tsunenari", "sequence": "additional", "affiliation": []}, {"given": "Miho", "family": "Watanabe", "sequence": "additional", "affiliation": []}, {"given": "Ayako", "family": "Nishimoto", "sequence": "additional", "affiliation": []}, {"given": "Ryo", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Toshito", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "Masateru", "family": "Ohta", "sequence": "additional", "affiliation": []}, {"given": "Noriyuki", "family": "Takata", "sequence": "additional", "affiliation": []}, {"given": "Kentaro", "family": "Furumoto", "sequence": "additional", "affiliation": []}, {"given": "Kazuya", "family": "Kimura", "sequence": "additional", "affiliation": []}, {"given": "Hiromitsu", "family": "Kawata", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bioorganic & Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0968089610009466?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0968089610009466?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 5]], "date-time": "2019-06-05T15:30:42Z", "timestamp": 1559748642000}, "score": 49.072105, "issued": {"date-parts": [[2010, 12]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "23"}, "alternative-id": ["S0968089610009466"], "URL": "http://dx.doi.org/10.1016/j.bmc.2010.10.023", "ISSN": ["0968-0896"], "issn-type": [{"value": "0968-0896", "type": "print"}]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:42:43Z", "timestamp": 1574808163916}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 4, 1]]}, "DOI": "10.21236/ada560736", "type": "report", "created": {"date-parts": [[2017, 7, 10]], "date-time": "2017-07-10T22:09:19Z", "timestamp": 1499724559000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Identification of Androgen Receptor-Regulated Genes in Castration-Recurrent Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Irwin H.", "family": "Gelman", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 10]], "date-time": "2017-07-10T22:09:19Z", "timestamp": 1499724559000}, "score": 45.669254, "subtitle": [""], "issued": {"date-parts": [[2012, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada560736"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:37:27Z", "timestamp": 1574833047814}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 4, 1]]}, "DOI": "10.21236/ada579454", "type": "report", "created": {"date-parts": [[2017, 9, 8]], "date-time": "2017-09-08T14:57:40Z", "timestamp": 1504882660000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Identification of Androgen Receptor-Regulated Genes in Castration-Recurrent Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Irwin H.", "family": "Gelman", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 9, 8]], "date-time": "2017-09-08T14:57:41Z", "timestamp": 1504882661000}, "score": 45.669254, "subtitle": [""], "issued": {"date-parts": [[2013, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada579454"}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T06:56:34Z", "timestamp": 1574578594384}, "reference-count": 46, "publisher": "Spandidos Publications", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015, 4]]}, "DOI": "10.3892/ijo.2015.2860", "type": "journal-article", "created": {"date-parts": [[2015, 1, 30]], "date-time": "2015-01-30T08:26:49Z", "timestamp": 1422606409000}, "page": "1560-1572", "source": "Crossref", "is-referenced-by-count": 3, "title": ["CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells"], "prefix": "10.3892", "volume": "46", "author": [{"given": "NOBUYUKI", "family": "ISHIKURA", "sequence": "first", "affiliation": []}, {"given": "HIROMITSU", "family": "KAWATA", "sequence": "additional", "affiliation": []}, {"given": "AYAKO", "family": "NISHIMOTO", "sequence": "additional", "affiliation": []}, {"given": "RYO", "family": "NAKAMURA", "sequence": "additional", "affiliation": []}, {"given": "TOSHIAKI", "family": "TSUNENARI", "sequence": "additional", "affiliation": []}, {"given": "MIHO", "family": "WATANABE", "sequence": "additional", "affiliation": []}, {"given": "KAZUTAKA", "family": "TACHIBANA", "sequence": "additional", "affiliation": []}, {"given": "TAKUYA", "family": "SHIRAISHI", "sequence": "additional", "affiliation": []}, {"given": "HITOSHI", "family": "YOSHINO", "sequence": "additional", "affiliation": []}, {"given": "AKIE", "family": "HONMA", "sequence": "additional", "affiliation": []}, {"given": "TAKASHI", "family": "EMURA", "sequence": "additional", "affiliation": []}, {"given": "MASATERU", "family": "OHTA", "sequence": "additional", "affiliation": []}, {"given": "TOSHITO", "family": "NAKAGAWA", "sequence": "additional", "affiliation": []}, {"given": "TAKAO", "family": "HOUJO", "sequence": "additional", "affiliation": []}, {"given": "EVA", "family": "COREY", "sequence": "additional", "affiliation": []}, {"given": "ROBERT L.", "family": "VESSELLA", "sequence": "additional", "affiliation": []}, {"given": "YUKO", "family": "AOKI", "sequence": "additional", "affiliation": []}, {"given": "HARUHIKO", "family": "SATO", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[2015, 1, 30]]}, "container-title": ["International Journal of Oncology"], "language": "en", "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.2015.2860/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 7]], "date-time": "2018-01-07T18:41:48Z", "timestamp": 1515350508000}, "score": 41.978584, "issued": {"date-parts": [[2015, 1, 30]]}, "references-count": 46, "journal-issue": {"published-online": {"date-parts": [[2015, 1, 30]]}, "published-print": {"date-parts": [[2015, 4]]}, "issue": "4"}, "alternative-id": ["10.3892/ijo.2015.2860"], "URL": "http://dx.doi.org/10.3892/ijo.2015.2860", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:19:41Z", "timestamp": 1574309981541}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "15", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2009, 8, 1]]}, "DOI": "10.1158/0008-5472.can-09-0395", "type": "journal-article", "created": {"date-parts": [[2009, 7, 8]], "date-time": "2009-07-08T03:24:27Z", "timestamp": 1247023467000}, "page": "6027-6032", "source": "Crossref", "is-referenced-by-count": 68, "title": ["Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer"], "prefix": "10.1158", "volume": "69", "author": [{"given": "C.", "family": "Cai", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Xu", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "S. P.", "family": "Balk", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2009, 7, 7]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-09-0395", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T08:54:22Z", "timestamp": 1482483262000}, "score": 40.34465, "issued": {"date-parts": [[2009, 7, 7]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 29]]}, "published-print": {"date-parts": [[2009, 8, 1]]}, "issue": "15"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-09-0395", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:08:14Z", "timestamp": 1574806094952}, "reference-count": 44, "publisher": "Wiley", "issue": "8", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000892", "name": "Prostate Cancer Foundation", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["R01 CA185297", "P30 CA006973"]}, {"name": "Patrick C. Walsh Fund", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Urol."], "published-print": {"date-parts": [[2016, 8]]}, "DOI": "10.1111/iju.13134", "type": "journal-article", "created": {"date-parts": [[2016, 6, 3]], "date-time": "2016-06-03T09:49:37Z", "timestamp": 1464947377000}, "page": "646-653", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations"], "prefix": "10.1111", "volume": "23", "author": [{"given": "Alan H", "family": "Bryce", "sequence": "first", "affiliation": [{"name": "Division of Hematology and Medical Oncology; Mayo Clinic; Scottsdale Arizona USA"}]}, {"given": "Emmanuel S", "family": "Antonarakis", "sequence": "additional", "affiliation": [{"name": "Departments of Oncology and Urology; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore Maryland USA"}]}], "member": "311", "published-online": {"date-parts": [[2016, 6, 3]]}, "reference": [{"key": "10.1111/iju.13134-BIB0001|iju13134-cit-0001", "first-page": "4552", "article-title": "Interrogating androgen receptor function in recurrent prostate cancer", "volume": "63", "author": "Zhang", "year": "2003", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0002|iju13134-cit-0002", "doi-asserted-by": "crossref", "first-page": "4792", "DOI": "10.1158/1078-0432.CCR-08-2660", "article-title": "Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer", "volume": "15", "author": "Knudsen", "year": "2009", "journal-title": "Clin. Cancer Res."}, {"key": "10.1111/iju.13134-BIB0003|iju13134-cit-0003", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat. Med."}, {"key": "10.1111/iju.13134-BIB0004|iju13134-cit-0004", "doi-asserted-by": "crossref", "first-page": "6503", "DOI": "10.1158/0008-5472.CAN-11-0532", "article-title": "Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors", "volume": "71", "author": "Cai", "year": "2011", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0005|iju13134-cit-0005", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1038/nrc4016", "article-title": "Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer", "volume": "15", "author": "Watson", "year": "2015", "journal-title": "Nat. Rev. Cancer"}, {"key": "10.1111/iju.13134-BIB0006|iju13134-cit-0006", "doi-asserted-by": "crossref", "first-page": "2855", "DOI": "10.1210/me.2007-0223", "article-title": "Androgen receptor structural and functional elements: role and regulation in prostate cancer", "volume": "21", "author": "Dehm", "year": "2007", "journal-title": "Mol. Endocrinol."}, {"key": "10.1111/iju.13134-BIB0007|iju13134-cit-0007", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/S1043-2760(04)00216-4", "article-title": "Intranuclear organization and function of the androgen receptor", "volume": "15", "author": "Black", "year": "2004", "journal-title": "Trends Endocrinol. Metab."}, {"issue": "Pt 7", "key": "10.1111/iju.13134-BIB0008|iju13134-cit-0008", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1242/jcs.022103", "article-title": "Structural basis for the nuclear import of the human androgen receptor", "volume": "121", "author": "Cutress", "year": "2008", "journal-title": "J. Cell Sci."}, {"key": "10.1111/iju.13134-BIB0009|iju13134-cit-0009", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1002/jcb.20794", "article-title": "Molecular regulation of androgen action in prostate cancer", "volume": "99", "author": "Dehm", "year": "2006", "journal-title": "J. Cell. Biochem."}, {"key": "10.1111/iju.13134-BIB0010|iju13134-cit-0010", "doi-asserted-by": "crossref", "first-page": "R183", "DOI": "10.1530/ERC-11-0141", "article-title": "Alternatively spliced androgen receptor variants", "volume": "18", "author": "Dehm", "year": "2011", "journal-title": "Endocr. Relat. Cancer"}, {"key": "10.1111/iju.13134-BIB0011|iju13134-cit-0011", "doi-asserted-by": "crossref", "first-page": "4758", "DOI": "10.1073/pnas.0401123101", "article-title": "Structural basis of androgen receptor binding to selective androgen response elements", "volume": "101", "author": "Shaffer", "year": "2004", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/iju.13134-BIB0012|iju13134-cit-0012", "doi-asserted-by": "crossref", "first-page": "8060", "DOI": "10.1074/jbc.M407046200", "article-title": "The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor", "volume": "280", "author": "Estebanez-Perpina", "year": "2005", "journal-title": "J. Biol. Chem."}, {"key": "10.1111/iju.13134-BIB0013|iju13134-cit-0013", "doi-asserted-by": "crossref", "first-page": "E274", "DOI": "10.1371/journal.pbio.0020274", "article-title": "Recognition and accommodation at the androgen receptor coactivator binding interface", "volume": "2", "author": "Hur", "year": "2004", "journal-title": "PLoS Biol."}, {"key": "10.1111/iju.13134-BIB0014|iju13134-cit-0014", "doi-asserted-by": "crossref", "first-page": "7866", "DOI": "10.1073/pnas.87.20.7866", "article-title": "Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity", "volume": "87", "author": "Ris-Stalpers", "year": "1990", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "10.1111/iju.13134-BIB0015|iju13134-cit-0015", "first-page": "6606", "article-title": "Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line", "volume": "62", "author": "Tepper", "year": "2002", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0016|iju13134-cit-0016", "doi-asserted-by": "crossref", "first-page": "5469", "DOI": "10.1158/0008-5472.CAN-08-0594", "article-title": "Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance", "volume": "68", "author": "Dehm", "year": "2008", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0017|iju13134-cit-0017", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1158/0008-5472.CAN-08-2764", "article-title": "Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer", "volume": "69", "author": "Hu", "year": "2009", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0018|iju13134-cit-0018", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1016/j.cell.2015.05.001", "article-title": "Integrative clinical genomics of advanced prostate cancer", "volume": "161", "author": "Robinson", "year": "2015", "journal-title": "Cell"}, {"key": "10.1111/iju.13134-BIB0019|iju13134-cit-0019", "first-page": "178", "article-title": "Decoding the androgen receptor splice variants", "volume": "2", "author": "Lu", "year": "2013", "journal-title": "Transl. Androl. Urol."}, {"key": "10.1111/iju.13134-BIB0020|iju13134-cit-0020", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1158/0008-5472.CAN-12-3630", "article-title": "Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines", "volume": "73", "author": "Li", "year": "2013", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0021|iju13134-cit-0021", "doi-asserted-by": "crossref", "first-page": "1859", "DOI": "10.1093/annonc/mdv282", "article-title": "Serial blood-based analysis of AR-V7 in men with advanced prostate cancer", "volume": "26", "author": "Nakazawa", "year": "2015", "journal-title": "Ann. Oncol."}, {"key": "10.1111/iju.13134-BIB0022|iju13134-cit-0022", "doi-asserted-by": "crossref", "first-page": "3457", "DOI": "10.1158/0008-5472.CAN-11-3892", "article-title": "Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer", "volume": "72", "author": "Hu", "year": "2012", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0023|iju13134-cit-0023", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/s12672-014-0190-1", "article-title": "Androgen receptor splice variants in the era of enzalutamide and abiraterone", "volume": "5", "author": "Nakazawa", "year": "2014", "journal-title": "Horm. Cancer"}, {"key": "10.1111/iju.13134-BIB0024|iju13134-cit-0024", "first-page": "2234", "article-title": "Resistance to androgen-pathway drugs in prostate cancer", "volume": "371", "author": "Antonarakis", "year": "2014", "journal-title": "N. Engl. J. Med."}, {"key": "10.1111/iju.13134-BIB0025|iju13134-cit-0025", "doi-asserted-by": "crossref", "first-page": "1028", "DOI": "10.1056/NEJMoa1315815", "article-title": "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer", "volume": "371", "author": "Antonarakis", "year": "2014", "journal-title": "N. Engl. J. Med."}, {"key": "10.1111/iju.13134-BIB0026|iju13134-cit-0026", "doi-asserted-by": "crossref", "first-page": "e279", "DOI": "10.1016/S1470-2045(15)70033-1", "article-title": "Sequencing of agents in castration-resistant prostate cancer", "volume": "16", "author": "Lorente", "year": "2015", "journal-title": "Lancet Oncol."}, {"key": "10.1111/iju.13134-BIB0027|iju13134-cit-0027", "author": "Steinestel", "year": "2015", "article-title": "Detecting predictive androgen receptor modifications in circulating prostate cancer cells", "journal-title": "Oncotarget", "DOI": "10.18632/oncotarget.3925", "doi-asserted-by": "publisher"}, {"issue": "2 Suppl", "key": "10.1111/iju.13134-BIB0028|iju13134-cit-0028", "first-page": "223", "article-title": "Correlation of a novel whole blood RT-PCR assay measuring AR-V7 expression with outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (ABI)", "volume": "34", "author": "Todenhofer", "year": "2016", "journal-title": "ASCO Meeting Abstracts"}, {"key": "10.1111/iju.13134-BIB0029|iju13134-cit-0029", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1001/jamaoncol.2015.1341", "article-title": "Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer", "volume": "1", "author": "Antonarakis", "year": "2015", "journal-title": "JAMA Oncol."}, {"key": "10.1111/iju.13134-BIB0030|iju13134-cit-0030", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1016/j.eururo.2015.07.007", "article-title": "Efficacy of cabazitaxel in castration-resistant prostate cancer is independent of the presence of AR-V7 in circulating tumor cells", "volume": "68", "author": "Onstenk", "year": "2015", "journal-title": "Eur. Urol."}, {"key": "10.1111/iju.13134-BIB0031|iju13134-cit-0031", "doi-asserted-by": "crossref", "first-page": "23358", "DOI": "10.18632/oncotarget.4396", "article-title": "Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents", "volume": "6", "author": "Zhang", "year": "2015", "journal-title": "Oncotarget"}, {"key": "10.1111/iju.13134-BIB0032|iju13134-cit-0032", "doi-asserted-by": "crossref", "first-page": "7992", "DOI": "10.1158/0008-5472.CAN-10-0585", "article-title": "Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer", "volume": "70", "author": "Zhu", "year": "2010", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0033|iju13134-cit-0033", "doi-asserted-by": "crossref", "first-page": "6019", "DOI": "10.1158/0008-5472.CAN-11-1417", "article-title": "Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer", "volume": "71", "author": "Darshan", "year": "2011", "journal-title": "Cancer Res."}, {"key": "10.1111/iju.13134-BIB0034|iju13134-cit-0034", "doi-asserted-by": "crossref", "first-page": "1805", "DOI": "10.1093/annonc/mdv311", "article-title": "Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: a coming of age for AR splice variants?", "volume": "26", "author": "Sprenger", "year": "2015", "journal-title": "Ann. Oncol."}, {"key": "10.1111/iju.13134-BIB0035|iju13134-cit-0035", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1007/s11864-015-0375-z", "article-title": "Clinical relevance of androgen receptor splice variants in castration-resistant prostate cancer", "volume": "16", "author": "Maughan", "year": "2015", "journal-title": "Curr. Treat. Options Oncol."}, {"key": "10.1111/iju.13134-BIB0036|iju13134-cit-0036", "doi-asserted-by": "crossref", "first-page": "27440", "DOI": "10.18632/oncotarget.4578", "article-title": "Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo", "volume": "6", "author": "Kwegyir-Afful", "year": "2015", "journal-title": "Oncotarget"}, {"issue": "Suppl 6", "key": "10.1111/iju.13134-BIB0037|iju13134-cit-0037", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1016/S0959-8049(14)70130-3", "article-title": "Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: results from ARMOR2", "volume": "50", "author": "Taplin", "year": "2014", "journal-title": "Eur. J. Cancer"}, {"key": "10.1111/iju.13134-BIB0038|iju13134-cit-0038", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1158/1078-0432.CCR-14-1108", "article-title": "Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth", "volume": "21", "author": "Yamamoto", "year": "2015", "journal-title": "Clin. Cancer Res."}, {"key": "10.1111/iju.13134-BIB0039|iju13134-cit-0039", "doi-asserted-by": "crossref", "first-page": "2948", "DOI": "10.1172/JCI66398", "article-title": "An androgen receptor N-terminal domain antagonist for treating prostate cancer", "volume": "123", "author": "Myung", "year": "2013", "journal-title": "J. Clin. Invest."}, {"key": "10.1111/iju.13134-BIB0040|iju13134-cit-0040", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1038/nature13229", "article-title": "Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer", "volume": "510", "author": "Asangani", "year": "2014", "journal-title": "Nature"}, {"key": "10.1111/iju.13134-BIB0041|iju13134-cit-0041", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1158/1541-7786.MCR-15-0472", "article-title": "BET bromodomain inhibitors enhance efficacy and disrupt resistance to AR antagonists in the treatment of prostate cancer", "volume": "14", "author": "Asangani", "year": "2016", "journal-title": "Mol. Cancer Res."}, {"key": "10.1111/iju.13134-BIB0042|iju13134-cit-0042", "doi-asserted-by": "crossref", "first-page": "3198", "DOI": "10.1158/1078-0432.CCR-13-3296", "article-title": "Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer", "volume": "20", "author": "Liu", "year": "2014", "journal-title": "Clin. Cancer Res."}, {"key": "10.1111/iju.13134-BIB0043|iju13134-cit-0043", "doi-asserted-by": "crossref", "first-page": "2509", "DOI": "10.1056/NEJMoa1500596", "article-title": "PD-1 blockade in tumors with mismatch-repair deficiency", "volume": "372", "author": "Le", "year": "2015", "journal-title": "N. Engl. J. Med."}, {"issue": "2 Suppl", "key": "10.1111/iju.13134-BIB0044|iju13134-cit-0044", "first-page": "109", "article-title": "Association of ARV7 expression with molecular and clinical characteristics in prostate cancer", "volume": "34", "author": "Joshi", "year": "2016", "journal-title": "ASCO Meeting Abstracts"}], "container-title": ["International Journal of Urology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fiju.13134", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T15:40:20Z", "timestamp": 1498318820000}, "score": 38.870697, "issued": {"date-parts": [[2016, 6, 3]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2016, 8]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1111/iju.13134", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0919-8172"], "issn-type": [{"value": "0919-8172", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T19:32:02Z", "timestamp": 1575487922564}, "reference-count": 0, "publisher": "Ivyspring International Publisher", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Biol. Sci."], "published-print": {"date-parts": [[2014]]}, "DOI": "10.7150/ijbs.8264", "type": "journal-article", "created": {"date-parts": [[2014, 6, 8]], "date-time": "2014-06-08T07:11:27Z", "timestamp": 1402211487000}, "page": "620-626", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Androgen Receptor Activation in Castration-Recurrent Prostate Cancer: The Role of Src-Family and Ack1 Tyrosine Kinases"], "prefix": "10.7150", "volume": "10", "author": [{"given": "Irwin H.", "family": "Gelman", "sequence": "first", "affiliation": []}], "member": "4137", "container-title": ["International Journal of Biological Sciences"], "language": "en", "link": [{"URL": "http://www.ijbs.com/v10p0620.htm", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 3, 27]], "date-time": "2017-03-27T00:30:28Z", "timestamp": 1490574628000}, "score": 38.11295, "issued": {"date-parts": [[2014]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.7150/ijbs.8264", "ISSN": ["1449-2288"], "issn-type": [{"value": "1449-2288", "type": "print"}], "subject": ["Developmental Biology", "Applied Microbiology and Biotechnology", "Cell Biology", "Ecology, Evolution, Behavior and Systematics", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T20:00:11Z", "timestamp": 1574539211802}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2013, 4, 15]]}, "DOI": "10.1158/1538-7445.am2013-3883", "type": "proceedings-article", "created": {"date-parts": [[2014, 8, 14]], "date-time": "2014-08-14T23:08:53Z", "timestamp": 1408057733000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3883: Robo1, a new target, by Wnt and androgen receptor signaling in castration resistant prostate cancer."], "prefix": "10.1158", "author": [{"given": "Noriko N.", "family": "Yokoyama", "sequence": "first", "affiliation": []}, {"given": "Zheng", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Toshinori", "family": "Sakai", "sequence": "additional", "affiliation": []}, {"given": "Bang H.", "family": "Hoang", "sequence": "additional", "affiliation": []}, {"given": "Xiaolin", "family": "Zi", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 18]]}, "event": {"name": "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC"}, "container-title": ["Tumor Biology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2013-3883", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T20:13:40Z", "timestamp": 1558210420000}, "score": 37.91455, "issued": {"date-parts": [[2013, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2013-3883"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2013-3883"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:59:13Z", "timestamp": 1574690353160}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1158/1538-7445.am2014-3314", "type": "proceedings-article", "created": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T21:52:23Z", "timestamp": 1430517143000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3314: Co-regulation of srGAP1 by Wnt and androgen receptor signaling in castration resistant prostate cancer"], "prefix": "10.1158", "author": [{"given": "Noriko N.", "family": "Yokoyama", "sequence": "first", "affiliation": []}, {"given": "Toshinori", "family": "Sakai", "sequence": "additional", "affiliation": []}, {"given": "Zheng", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Shujuan", "family": "Shao", "sequence": "additional", "affiliation": []}, {"given": "Jiaoti", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "Bang H.", "family": "Hoang", "sequence": "additional", "affiliation": []}, {"given": "Xiaolin", "family": "Zi", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 9, 30]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA"}, "container-title": ["Molecular and Cellular Biology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2014-3314", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T15:46:03Z", "timestamp": 1558194363000}, "score": 37.91455, "issued": {"date-parts": [[2014, 9, 30]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2014-3314"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2014-3314"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:48:49Z", "timestamp": 1574822929298}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004, 2, 1]]}, "DOI": "10.21236/ada423669", "type": "report", "created": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T15:14:34Z", "timestamp": 1502723674000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Inhibitory Ah Receptor - Androgen Receptor Crosstalk in Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Stephen H.", "family": "Safe", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T15:14:34Z", "timestamp": 1502723674000}, "score": 36.034103, "subtitle": [""], "issued": {"date-parts": [[2004, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada423669"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:40:08Z", "timestamp": 1574401208815}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "19", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2011, 10, 1]]}, "DOI": "10.1158/0008-5472.can-11-1520", "type": "journal-article", "created": {"date-parts": [[2011, 9, 21]], "date-time": "2011-09-21T02:28:09Z", "timestamp": 1316572089000}, "page": "6250-6260", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Androgen-Independent Molecular Imaging Vectors to Detect Castration-Resistant and Metastatic Prostate Cancer"], "prefix": "10.1158", "volume": "71", "author": [{"given": "Z. K.", "family": "Jiang", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Sato", "sequence": "additional", "affiliation": []}, {"given": "L. H.", "family": "Wei", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Kao", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Wu", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2011, 9, 20]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-11-1520", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T05:27:52Z", "timestamp": 1482470872000}, "score": 35.40526, "issued": {"date-parts": [[2011, 9, 20]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 9, 29]]}, "published-print": {"date-parts": [[2011, 10, 1]]}, "issue": "19"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-11-1520", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:00:59Z", "timestamp": 1574892059081}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "suppl_8", "license": [{"URL": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model", "start": {"date-parts": [[2018, 10, 23]], "date-time": "2018-10-23T00:00:00Z", "timestamp": 1540252800000}, "delay-in-days": 22, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 10, 1]]}, "DOI": "10.1093/annonc/mdy284.045", "type": "journal-article", "created": {"date-parts": [[2018, 10, 24]], "date-time": "2018-10-24T21:43:45Z", "timestamp": 1540417425000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["836PUse of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC)"], "prefix": "10.1093", "volume": "29", "author": [{"given": "H I", "family": "Scher", "sequence": "first", "affiliation": [{"name": "Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"}]}, {"given": "R P", "family": "Graf", "sequence": "additional", "affiliation": [{"name": "Translational Research, Epic Sciences, Inc., San Diego, CA, USA"}]}, {"given": "M", "family": "Hulling", "sequence": "additional", "affiliation": [{"name": "Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"}]}, {"given": "E", "family": "Carbone", "sequence": "additional", "affiliation": [{"name": "Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"}]}, {"given": "R", "family": "Dittamore", "sequence": "additional", "affiliation": [{"name": "Translational Research, Epic Sciences, Inc., San Diego, CA, USA"}]}], "member": "286", "published-online": {"date-parts": [[2018, 10, 23]]}, "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy284.045/26140064/mdy284.045.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 25]], "date-time": "2018-10-25T02:05:51Z", "timestamp": 1540433151000}, "score": 35.395046, "issued": {"date-parts": [[2018, 10, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018, 10, 23]]}, "published-print": {"date-parts": [[2018, 10, 1]]}, "issue": "suppl_8"}, "URL": "http://dx.doi.org/10.1093/annonc/mdy284.045", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T02:29:50Z", "timestamp": 1574562590745}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1016/s0959-8049(14)70560-x", "type": "journal-article", "created": {"date-parts": [[2014, 11, 21]], "date-time": "2014-11-21T00:30:14Z", "timestamp": 1416529814000}, "page": "143", "source": "Crossref", "is-referenced-by-count": 0, "title": ["434 Bipolar androgen therapy for men with castration sensitive and castration resistant prostate cancer: Reversing resistance and maintaining sensitivity to androgen ablative therapies"], "prefix": "10.1016", "volume": "50", "author": [{"given": "S.R.", "family": "Denmeade", "sequence": "first", "affiliation": []}, {"given": "E.S.", "family": "Antonarakis", "sequence": "additional", "affiliation": []}, {"given": "M.A.", "family": "Eisenberger", "sequence": "additional", "affiliation": []}, {"given": "M.A.", "family": "Carducci", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "C.J.", "family": "Paller", "sequence": "additional", "affiliation": []}, {"given": "J.T.", "family": "Isaacs", "sequence": "additional", "affiliation": []}, {"given": "M.T.", "family": "Schweizer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S095980491470560X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S095980491470560X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T15:50:29Z", "timestamp": 1538063429000}, "score": 35.24541, "issued": {"date-parts": [[2014, 11]]}, "references-count": 0, "alternative-id": ["S095980491470560X"], "URL": "http://dx.doi.org/10.1016/s0959-8049(14)70560-x", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:15:36Z", "timestamp": 1574889336486}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T00:00:00Z", "timestamp": 1556668800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2019, 5]]}, "DOI": "10.1016/s1569-9056(19)32143-8", "type": "journal-article", "created": {"date-parts": [[2019, 6, 10]], "date-time": "2019-06-10T11:10:16Z", "timestamp": 1560165016000}, "page": "e2429", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer"], "prefix": "10.1016", "volume": "18", "author": [{"given": "K.", "family": "Stuopelyte", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Bakavicius", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Sabaliauskaite", "sequence": "additional", "affiliation": []}, {"given": "B.S.", "family": "Haflidad\u00f3ttir", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Visakorpi", "sequence": "additional", "affiliation": []}, {"given": "R.M.", "family": "V\u00e4\u00e4n\u00e4nen", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Patel", "sequence": "additional", "affiliation": []}, {"given": "D.C.", "family": "Danila", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Lilja", "sequence": "additional", "affiliation": []}, {"given": "J.R.", "family": "Lazutka", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Ulys", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Jankevicius", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Jarmalaite", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1569905619321438?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1569905619321438?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 10]], "date-time": "2019-06-10T11:10:17Z", "timestamp": 1560165017000}, "score": 35.077667, "issued": {"date-parts": [[2019, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 5]]}, "issue": "3"}, "alternative-id": ["S1569905619321438"], "URL": "http://dx.doi.org/10.1016/s1569-9056(19)32143-8", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:30:14Z", "timestamp": 1574404214914}, "reference-count": 42, "publisher": "Wiley", "issue": "7", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2063, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2010, 5, 15]]}, "DOI": "10.1002/pros.21107", "type": "journal-article", "created": {"date-parts": [[2010, 1, 7]], "date-time": "2010-01-07T19:26:13Z", "timestamp": 1262892373000}, "page": "745-754", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity"], "prefix": "10.1002", "volume": "70", "author": [{"given": "Hiromitsu", "family": "Kawata", "sequence": "first", "affiliation": []}, {"given": "Nobuyuki", "family": "Ishikura", "sequence": "additional", "affiliation": []}, {"given": "Miho", "family": "Watanabe", "sequence": "additional", "affiliation": []}, {"given": "Ayako", "family": "Nishimoto", "sequence": "additional", "affiliation": []}, {"given": "Toshiaki", "family": "Tsunenari", "sequence": "additional", "affiliation": []}, {"given": "Yuko", "family": "Aoki", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 1, 7]]}, "reference": [{"issue": "4", "key": "10.1002/pros.21107-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1093/annonc/mdm597", "article-title": "Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis", "volume": "19", "author": "Bosetti", "year": "2008", "journal-title": "Ann Oncol"}, {"issue": "9", "key": "10.1002/pros.21107-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1093/jjco/hyn074", "article-title": "Cancer incidence and incidence rates in Japan in 2002: Based on data from 11 population-based cancer registries", "volume": "38", "author": "Matsuda", "year": "2008", "journal-title": "Jpn J Clin Oncol"}, {"issue": "2", "key": "10.1002/pros.21107-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1002/ijc.23911", "article-title": "A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)", "volume": "124", "author": "Qiu", "year": "2009", "journal-title": "Int J Cancer"}, {"issue": "2", "key": "10.1002/pros.21107-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.3322/CA.2007.0010", "article-title": "Cancer statistics, 2008", "volume": "58", "author": "Jemal", "year": "2008", "journal-title": "CA Cancer J Clin"}, {"issue": "5", "key": "10.1002/pros.21107-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1053/hp.2000.6698", "article-title": "Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients", "volume": "31", "author": "Bubendorf", "year": "2000", "journal-title": "Hum Pathol"}, {"issue": "7", "key": "10.1002/pros.21107-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/S0046-8177(03)00190-4", "article-title": "Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone", "volume": "34", "author": "Roudier", "year": "2003", "journal-title": "Hum Pathol"}, {"issue": "24", "key": "10.1002/pros.21107-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "9209", "DOI": "10.1158/0008-5472.CAN-04-2442", "article-title": "Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program", "volume": "64", "author": "Shah", "year": "2004", "journal-title": "Cancer Res"}, {"issue": "15", "key": "10.1002/pros.21107-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "3437", "DOI": "10.1002/cncr.24395", "article-title": "Combined androgen blockade with bicalutamide for advanced prostate cancer: Long-term follow-up of a phase 3, double-blind, randomized study for survival", "volume": "115", "author": "Akaza", "year": "2009", "journal-title": "Cancer"}, {"issue": "12", "key": "10.1002/pros.21107-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1007/s00432-008-0409-z", "article-title": "Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: A multicenter, randomized, double-blind, comparative study", "volume": "134", "author": "Arai", "year": "2008", "journal-title": "J Cancer Res Clin Oncol"}, {"issue": "5", "key": "10.1002/pros.21107-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1046/j.1464-410X.2003.04026.x", "article-title": "The role of antiandrogen monotherapy in the treatment of prostate cancer", "volume": "91", "author": "Anderson", "year": "2003", "journal-title": "BJU Int"}, {"issue": "2", "key": "10.1002/pros.21107-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1111/j.1464-410X.2005.06051.x", "article-title": "Bicalutamide 150\u2009mg plus standard care vs standard care alone for early prostate cancer", "volume": "97", "author": "McLeod", "year": "2006", "journal-title": "BJU Int"}, {"issue": "10", "key": "10.1002/pros.21107-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "3251", "DOI": "10.1158/1078-0432.CCR-08-1171", "article-title": "Castration-resistant prostate cancer: Locking up the molecular escape routes", "volume": "15", "author": "Attar", "year": "2009", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "10.1002/pros.21107-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1665", "DOI": "10.1158/1078-0432.CCR-06-0067", "article-title": "Mechanisms underlying the development of androgen-independent prostate cancer", "volume": "12", "author": "Pienta", "year": "2006", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "10.1002/pros.21107-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1129", "DOI": "10.1016/j.eururo.2008.01.049", "article-title": "Progress in understanding androgen-independent prostate cancer (AIPC): A review of potential endocrine-mediated mechanisms", "volume": "53", "author": "Schroder", "year": "2008", "journal-title": "Eur Urol"}, {"issue": "6", "key": "10.1002/pros.21107-BIB15|cit15", "first-page": "1566", "article-title": "Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation", "volume": "54", "author": "Kokontis", "year": "1994", "journal-title": "Cancer Res"}, {"issue": "3", "key": "10.1002/pros.21107-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1002/(SICI)1097-4652(199906)179:3<336::AID-JCP11>3.0.CO;2-Q", "article-title": "Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative", "volume": "179", "author": "Gao", "year": "1999", "journal-title": "J Cell Physiol"}, {"issue": "2", "key": "10.1002/pros.21107-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1038/sj.bjc.6690684", "article-title": "Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system", "volume": "81", "author": "Culig", "year": "1999", "journal-title": "Br J Cancer"}, {"issue": "5", "key": "10.1002/pros.21107-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/S0960-0760(00)00076-5", "article-title": "Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line", "volume": "73", "author": "Joly-Pharaboz", "year": "2000", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "11", "key": "10.1002/pros.21107-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "5054", "DOI": "10.1210/endo.140.11.7086", "article-title": "Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells", "volume": "140", "author": "Lu", "year": "1999", "journal-title": "Endocrinology"}, {"issue": "4", "key": "10.1002/pros.21107-BIB20|cit20", "first-page": "220", "article-title": "Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells", "volume": "6", "author": "Tso", "year": "2000", "journal-title": "Cancer J"}, {"issue": "4", "key": "10.1002/pros.21107-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1002/pros.20145", "article-title": "Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis", "volume": "62", "author": "Gustavsson", "year": "2005", "journal-title": "Prostate"}, {"issue": "12", "key": "10.1002/pros.21107-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "1293", "DOI": "10.1002/pros.20621", "article-title": "Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line", "volume": "67", "author": "Lee", "year": "2007", "journal-title": "Prostate"}, {"issue": "3", "key": "10.1002/pros.21107-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1111/j.1442-2042.2007.01532.x", "article-title": "Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP", "volume": "14", "author": "Iwasa", "year": "2007", "journal-title": "Int J Urol"}, {"issue": "1", "key": "10.1002/pros.21107-BIB24|cit24", "first-page": "149", "article-title": "Novel mutations of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome", "volume": "63", "author": "Hara", "year": "2003", "journal-title": "Cancer Res"}, {"issue": "4", "key": "10.1002/pros.21107-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1002/pros.20285", "article-title": "Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity", "volume": "65", "author": "Kokontis", "year": "2005", "journal-title": "Prostate"}, {"issue": "4", "key": "10.1002/pros.21107-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1002/pros.20365", "article-title": "The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide", "volume": "66", "author": "Hobisch", "year": "2006", "journal-title": "Prostate"}, {"issue": "5", "key": "10.1002/pros.21107-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.2164/jandrol.04164", "article-title": "Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous androgen measurement method", "volume": "26", "author": "Kashiwagi", "year": "2005", "journal-title": "J Androl"}, {"issue": "1", "key": "10.1002/pros.21107-BIB28|cit28", "first-page": "81", "article-title": "Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer", "volume": "99", "author": "Uemura", "year": "2008", "journal-title": "Cancer Sci"}, {"issue": "3", "key": "10.1002/pros.21107-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1002/pros.10290", "article-title": "Molecular characterization of human prostate carcinoma cell lines", "volume": "57", "author": "van Bokhoven", "year": "2003", "journal-title": "Prostate"}, {"issue": "1", "key": "10.1002/pros.21107-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nm972", "article-title": "Molecular determinants of resistance to antiandrogen therapy", "volume": "10", "author": "Chen", "year": "2004", "journal-title": "Nat Med"}, {"issue": "3", "key": "10.1002/pros.21107-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1038/sj.bjc.6601127", "article-title": "Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer", "volume": "89", "author": "Edwards", "year": "2003", "journal-title": "Br J Cancer"}, {"issue": "1", "key": "10.1002/pros.21107-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0002-9440(10)63112-4", "article-title": "Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance", "volume": "164", "author": "Holzbeierlein", "year": "2004", "journal-title": "Am J Pathol"}, {"issue": "2", "key": "10.1002/pros.21107-BIB33|cit33", "first-page": "314", "article-title": "Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer", "volume": "57", "author": "Koivisto", "year": "1997", "journal-title": "Cancer Res"}, {"issue": "5", "key": "10.1002/pros.21107-BIB34|cit34", "first-page": "1919", "article-title": "Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays", "volume": "61", "author": "Latil", "year": "2001", "journal-title": "Cancer Res"}, {"issue": "9", "key": "10.1002/pros.21107-BIB35|cit35", "first-page": "3550", "article-title": "Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer", "volume": "61", "author": "Linja", "year": "2001", "journal-title": "Cancer Res"}, {"issue": "4", "key": "10.1002/pros.21107-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1038/ng0495-401", "article-title": "In vivo amplification of the androgen receptor gene and progression of human prostate cancer", "volume": "9", "author": "Visakorpi", "year": "1995", "journal-title": "Nat Genet"}, {"issue": "51", "key": "10.1002/pros.21107-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "50902", "DOI": "10.1074/jbc.M300676200", "article-title": "Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers", "volume": "278", "author": "Lin", "year": "2003", "journal-title": "J Biol Chem"}, {"issue": "13", "key": "10.1002/pros.21107-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "7200", "DOI": "10.1073/pnas.121173298", "article-title": "Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor", "volume": "98", "author": "Lin", "year": "2001", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "6", "key": "10.1002/pros.21107-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1038/sj.bjc.6604152", "article-title": "Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients", "volume": "98", "author": "McCall", "year": "2008", "journal-title": "Br J Cancer"}, {"issue": "5928", "key": "10.1002/pros.21107-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1126/science.1168175", "article-title": "Development of a second-generation antiandrogen for treatment of advanced prostate cancer", "volume": "324", "author": "Tran", "year": "2009", "journal-title": "Science"}, {"issue": "28", "key": "10.1002/pros.21107-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "4563", "DOI": "10.1200/JCO.2007.15.9749", "article-title": "Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven", "volume": "26", "author": "Attard", "year": "2008", "journal-title": "J Clin Oncol"}, {"issue": "12", "key": "10.1002/pros.21107-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "2317", "DOI": "10.1038/sj.bjc.6601879", "article-title": "Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer", "volume": "90", "author": "O'Donnell", "year": "2004", "journal-title": "Br J Cancer"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21107", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 25]], "date-time": "2019-02-25T14:05:21Z", "timestamp": 1551103521000}, "score": 34.04442, "issued": {"date-parts": [[2010, 1, 7]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2010, 5, 15]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1002/pros.21107", "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T10:08:25Z", "timestamp": 1574849305640}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 10, 1]], "date-time": "2017-10-01T00:00:00Z", "timestamp": 1506816000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T00:00:00Z", "timestamp": 1538352000000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Value in Health"], "published-print": {"date-parts": [[2017, 10]]}, "DOI": "10.1016/j.jval.2017.08.416", "type": "journal-article", "created": {"date-parts": [[2017, 10, 20]], "date-time": "2017-10-20T10:32:06Z", "timestamp": 1508495526000}, "page": "A471-A472", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Guideline Adherence In Docetaxel Treatment Of Castration Resistant Prostate Cancer (CRPC) Patients In A Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) In The Netherlands"], "prefix": "10.1016", "volume": "20", "author": [{"given": "H", "family": "Westgeest", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Kuppen", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Van den Eertwegh", "sequence": "additional", "affiliation": []}, {"given": "W", "family": "Gerritsen", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Uyl-de Groot", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Value in Health"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1098301517307507?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1098301517307507?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T03:35:25Z", "timestamp": 1538364925000}, "score": 33.303757, "issued": {"date-parts": [[2017, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 10]]}, "issue": "9"}, "alternative-id": ["S1098301517307507"], "URL": "http://dx.doi.org/10.1016/j.jval.2017.08.416", "ISSN": ["1098-3015"], "issn-type": [{"value": "1098-3015", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}